Floaters and reduced contrast sensitivity after successful pharmacologic vitreolysis with ocriplasmin

PURPOSE: To describe the onset of floaters and reduction in contrast sensitivity (CS) following successful pharmacologic vitreolysis with ocriplasmin for the treatment of vitreo-macular traction (VMT) in a patient with previously normal CS. OBSERVATIONS: A 65-year-old woman with a past ocular histor...

Descripción completa

Detalles Bibliográficos
Autores principales: Khoshnevis, Matin, Nguyen-Cuu, Jeannie, Sebag, J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2016
Materias:
Case report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5757454/
https://www.ncbi.nlm.nih.gov/pubmed/29503926
http://dx.doi.org/10.1016/j.ajoc.2016.08.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5757454/
https://www.ncbi.nlm.nih.gov/pubmed/29503926
http://dx.doi.org/10.1016/j.ajoc.2016.08.005

Ejemplares similares